Overview
HIV Drug Resistance Databases contain genetic records of HIV-1 viruses which are known to have developed a resistance to antiretroviral therapies. This data is important in understanding the potential for development of drug resistance and in designing new strategies to treat HIV. The databases serve as a tool for ongoing research and monitoring of emerging drug-resistant strains of the virus. By providing a comprehensive resource for researchers, clinicians, and public health professionals, these databases help in the development of more effective drugs, treatments, and prevention strategies.
Research published in this journal
2 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Supporting Quality Data Systems: Lessons Learned from Early Implementation of Routine Viral Load Monitoring at a Large Clinic in Lilongwe, Malawi
How this research is being cited
The 2 articles above have been cited 16 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
H. Adhiambo et al. · 2025 · PLOS Global Public Health
-
2025 · PLOS Global Public Health
-
2024 · medRxiv (Cold Spring Harbor Laboratory)
-
A. Waljee et al. · 2022 · Gut
-
2022 · Gut
-
M. Wambura et al. · 2020 · PLoS ONE
-
E. Zimmerman et al. · 2020 ·
-
2020 · PLoS ONE
A sample of recent works citing this journal's research on Hiv Drug Resistance Databases, linking to each citing work.